mutLBSgeneDB |
Gene summary for IL5RA |
Gene summary |
Basic gene Info. | Gene symbol | IL5RA |
Gene name | interleukin 5 receptor, alpha | |
Synonyms | CD125|CDw125|HSIL5R3|IL5R | |
Cytomap | UCSC genome browser: 3p26-p24 | |
Type of gene | protein-coding | |
RefGenes | NM_000564.4, NM_001243099.1,NM_175724.2,NM_175725.2,NM_175726.3, NM_175727.2,NM_175728.2, | |
Description | CD125 antigenIL-5 receptor subunit alphaIL-5R subunit alphainterleukin 5 receptor type 3interleukin-5 receptor alpha chaininterleukin-5 receptor subunit alpha | |
Modification date | 20141207 | |
dbXrefs | MIM : 147851 | |
HGNC : HGNC | ||
Ensembl : ENSG00000091181 | ||
HPRD : 00998 | ||
Vega : OTTHUMG00000090245 | ||
Protein | UniProt: Q01344 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_IL5RA | |
BioGPS: 3568 | ||
Pathway | NCI Pathway Interaction Database: IL5RA | |
KEGG: IL5RA | ||
REACTOME: IL5RA | ||
Pathway Commons: IL5RA | ||
Context | iHOP: IL5RA | |
ligand binding site mutation search in PubMed: IL5RA | ||
UCL Cancer Institute: IL5RA | ||
Assigned class in mutLBSgeneDB | B: This gene belongs to targetable_mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID |
Top |
Ligand binding site mutations for IL5RA |
Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.) : non-synonymous mutation on LBS, Circle size denotes number of samples. |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | Y172 | L171I | COAD | 2 | K68 | V67E | BRCA | 1 | Y172 | R174G | LUAD | 1 | S115 | A116S | LUSC | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for IL5RA |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | S115 | A116S | 0.6392426 | Y172 | R174G | -1.828544 | Y172 | L171I | -1.3347362 | K68 | V67E | -1.1756804 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for IL5RA from PDB |
PDB ID | PDB title | PDB structure | 3QT2 | Structure of a cytokine ligand-receptor complex |
Top |
Differential gene expression and gene-gene network for IL5RA |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for IL5RA |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
umls:C0000786 | Abortion, Spontaneous | 1 | Biomarker |
umls:C0020517 | Hypersensitivity | 1 | Biomarker |
umls:C0032285 | Pneumonia | 1 | Biomarker |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for IL5RA |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of IL5RA go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS |
Top |
Conservation information for LBS of IL5RA |
Multiple alignments for Q01344 in multiple species |
LBS | AA sequence | # species | Species |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |